These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10683544)

  • 61. [Hepatitis B in Poland in 2001].
    Kuszewski K; Czarkowski MP
    Przegl Epidemiol; 2003; 57(1):117-23. PubMed ID: 12926317
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Implementation in Italy of a universal vaccination programme against hepatitis B.
    Bonanni P
    Vaccine; 1995; 13 Suppl 1():S68-71. PubMed ID: 7571837
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Implementing universal vaccination programmes: Bulgaria.
    Gatcheva N; Vladimirova N; Kourtchatova A
    Vaccine; 1995; 13 Suppl 1():S82-3. PubMed ID: 7571842
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Immunization coverage of children aged 0 to 5 years in Libreville (Gabon)].
    Ategbo S; Ngoungou EB; Koko J; Vierin Y; Zang Ndong CE; Moussavou Mouyama A
    Sante; 2010; 20(4):215-9. PubMed ID: 21266317
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers.
    Doherty R; Garland S; Wright M; Bulotsky M; Liss C; Lakkis H; Nikas A; Straus W
    Pediatr Infect Dis J; 2009 Sep; 28(9):777-81. PubMed ID: 19636283
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Compliance with birth dose of Hepatitis B vaccine in high endemic and hard to reach areas in the Colombian amazon: results from a vaccination survey.
    Choconta-Piraquive LA; De la Hoz-Restrepo F; Sarmiento-Limas CA
    BMC Health Serv Res; 2016 Jul; 16():293. PubMed ID: 27443313
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Avdicova M; Crasta PD; Hardt K; Kovac M
    Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period.
    Park NH; Chung YH; Lee HS
    Intervirology; 2010; 53(1):20-8. PubMed ID: 20068337
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Hepatitis B in Poland in 2000].
    Kuszewski K; Swiderska H
    Przegl Epidemiol; 2002; 56(2):319-23. PubMed ID: 12371366
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Incidence of hepatocellular carcinoma in children in Khon Kaen before and after national hepatitis B vaccine program.
    Wichajarn K; Kosalaraksa P; Wiangnon S
    Asian Pac J Cancer Prev; 2008; 9(3):507-9. PubMed ID: 18990029
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Primary prevention by hepatitis B vaccine on liver cancer in high incidence area of China].
    Wang YT; Chen TY; Zhu J; Jiao YC; Qu CF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Apr; 52(4):402-408. PubMed ID: 29614608
    [No Abstract]   [Full Text] [Related]  

  • 73. A mass hepatitis B vaccination programme in Taiwan: its preparation, results and reasons for uncompleted vaccinations.
    Wong WC; Tsang KK
    Vaccine; 1994; 12(3):229-34. PubMed ID: 8165855
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The cost of integrating hepatitis B virus vaccine into national immunization programmes: a case study from Addis Ababa.
    Edmunds W; Dejene A; Mekonnen Y; Haile M; Alemnu W; Nokes D
    Health Policy Plan; 2000 Dec; 15(4):408-16. PubMed ID: 11124244
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Progress in vaccination towards hepatitis B control and elimination in the Region of the Americas.
    Ropero Álvarez AM; Pérez-Vilar S; Pacis-Tirso C; Contreras M; El Omeiri N; Ruiz-Matus C; Velandia-González M
    BMC Public Health; 2017 Apr; 17(1):325. PubMed ID: 28415981
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth.
    Gatchalian S; Reyes M; Bernal N; Lefevre I; David MP; Han HH; Bock HL; Wolter J; Schuerman L
    Hum Vaccin; 2005; 1(5):198-203. PubMed ID: 17012860
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Integration of hepatitis B vaccination into rural African primary health care programmes.
    Schoub BD; Johnson S; McAnerney JM; Blackburn N; Kew MC; McCutcheon JP; Carlier ND
    BMJ; 1991 Feb; 302(6772):313-6. PubMed ID: 1825799
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Vaccination against pneumococci and hepatitis B in the Dutch National Immunisation Programme].
    Boot HJ; Schouls L; Hahné S; Berbers GA; van de Laar M; Kimman TG
    Ned Tijdschr Geneeskd; 2007 Jan; 151(3):172-6. PubMed ID: 17288341
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hepatitis B school-based vaccination programmes in the USA: a model for hepatitis A and B.
    Koff RS
    Vaccine; 2000 Feb; 18 Suppl 1():S77-9. PubMed ID: 10683556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.